Google and its sister company Verily announced on Monday, Feb. 25, the development of an AI-based algorithm that can screen eye imaging exams for diabetic retinopathy and diabetic macular edema—two of the leading causes of preventable blindness in adults with diabetes, according to a recent report by CNBC.  

Zebra Medical Vision, a Shefayim, Israel-based medical imaging analytics company, announced that it has received CE certification for two AI-based algorithms aimed at improving care in the emergency department (ED).

Aidoc, a Tel-Aviv, Israel-based medical imaging company, announced that its AI-based solution for improving pulmonary embolism (PE) workflow has received CE certification.

A new AI-based software called the Ensemble Algorithm with Multiple Parcellations for Schizophrenia Prediction, or EMPaSchiz, can identify schizophrenia on fMRI scans with 87 percent accuracy, according to a recent report by AI in Healthcare.  

Aidoc’s solution for flagging and prioritizing pulmonary embolisms is now commercially available in Europe

Mammography is an essential screening and diagnostic tool for the detection of breast cancer and the assessment of breast density. But, according to Victoria L. Mango, MD, a breast radiologist at Memorial Sloan Kettering Cancer Center in New York City, AI can help breast imagers and physicians see beyond basic breast density information provided by mammographic images and improve clinical management overall.

Researchers have developed new AI models that can predict when atypical ductal hyperplasia (ADH) breast lesions will be cancerous, publishing their findings in JCO Clinical Cancer Informatics.

After seeing success from its AI-powered healthcare bot, Ohio-based healthcare technology company Olive is planning to add 100 tech jobs within the next two years, according to a report by Columbus Business First.